Donate

Jennifer Kaoru Bando, Ph.D., Postdoctoral Fellow Washington University School of Medicine

“I hope to contribute to our understanding of innate immune regulation and stromal-immune interactions.”

Area of Research: All Cancers

IL-22 is a molecule that is important in intestinal epithelial homeostasis, but that may also contribute to tumor cell division and survival. IL-22 is produced by immune cells, including subsets of innate lymphoid cells that mainly reside in mucosal tissues.

The overall goal of Dr. Bando’s research is to decipher how IL-22 secretion by innate lymphoid cells is regulated in different organs in order to develop strategies to control the production of this cytokine.

Projects and Grants

Immune modulation of dormant skin tumor development and persistence

Washington University School of Medicine | All Cancers | 2016 | Marco Colonna, M.D.

Let's spread the word about Immunotherapy! Click to share this page with your community.

Copy Link

*Immunotherapy results may vary from patient to patient.

Cancer Research Institute | National Headquarters
29 Broadway, Floor 4 | New York, NY 10006-3111

800-992-2623 212-832-9376 Staff Directory

Stay Connected with CRI

Recent Blog Posts

This September for Childhood Cancer Awareness Month, we look at new research, new treatments, and how we are working toward a future immune to childhood cancer.

This September for Gynecologic Cancer Awareness Month, we reflect on new treatments, research discoveries, and how CRI is making its impact on a future immune to cervical, ovarian, and uterine cancers.

Top